Edoardo Caronna

1.7k total citations
55 papers, 907 citations indexed

About

Edoardo Caronna is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Edoardo Caronna has authored 55 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Psychiatry and Mental health, 24 papers in Pathology and Forensic Medicine and 18 papers in Neurology. Recurrent topics in Edoardo Caronna's work include Migraine and Headache Studies (45 papers), Trigeminal Neuralgia and Treatments (23 papers) and Long-Term Effects of COVID-19 (12 papers). Edoardo Caronna is often cited by papers focused on Migraine and Headache Studies (45 papers), Trigeminal Neuralgia and Treatments (23 papers) and Long-Term Effects of COVID-19 (12 papers). Edoardo Caronna collaborates with scholars based in Spain, United States and Italy. Edoardo Caronna's co-authors include Patricia Pozo‐Rosich, Marta Torres‐Ferrús, Alicia Alpuente, Victor J Gallardo, Arnau Llauradó, Sofía Lallana, Juan Luis Restrepo‐Vera, Marc Rodrigo‐Gisbert, Marta Olivé‐Gadea and José Álvarez‐Sabín and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Annals of Neurology.

In The Last Decade

Edoardo Caronna

50 papers receiving 900 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edoardo Caronna Spain 17 621 406 295 149 143 55 907
Victor J Gallardo Spain 15 599 1.0× 298 0.7× 303 1.0× 108 0.7× 159 1.1× 43 784
Alicia Alpuente Spain 15 577 0.9× 265 0.7× 311 1.1× 94 0.6× 150 1.0× 45 745
Marta Torres‐Ferrús Spain 16 828 1.3× 321 0.8× 440 1.5× 101 0.7× 240 1.7× 58 1.0k
Ana Beatriz Gago‐Veiga Spain 16 442 0.7× 253 0.6× 174 0.6× 108 0.7× 77 0.5× 67 658
Guus Schoonman Netherlands 18 826 1.3× 365 0.9× 412 1.4× 27 0.2× 227 1.6× 37 1.2k
Bianca Raffaelli Germany 22 1.2k 1.9× 206 0.5× 694 2.4× 74 0.5× 364 2.5× 69 1.4k
Axel Heinze Germany 14 394 0.6× 245 0.6× 181 0.6× 20 0.1× 171 1.2× 33 749
Alejandro Labastida‐Ramírez Netherlands 16 707 1.1× 160 0.4× 359 1.2× 39 0.3× 224 1.6× 30 893
Marcello Silvestro Italy 16 655 1.1× 142 0.3× 349 1.2× 34 0.2× 153 1.1× 57 814
Eloísa Rubio‐Beltrán Netherlands 17 784 1.3× 124 0.3× 422 1.4× 34 0.2× 279 2.0× 35 1.1k

Countries citing papers authored by Edoardo Caronna

Since Specialization
Citations

This map shows the geographic impact of Edoardo Caronna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edoardo Caronna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edoardo Caronna more than expected).

Fields of papers citing papers by Edoardo Caronna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edoardo Caronna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edoardo Caronna. The network helps show where Edoardo Caronna may publish in the future.

Co-authorship network of co-authors of Edoardo Caronna

This figure shows the co-authorship network connecting the top 25 collaborators of Edoardo Caronna. A scholar is included among the top collaborators of Edoardo Caronna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edoardo Caronna. Edoardo Caronna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caronna, Edoardo, et al.. (2025). Effectiveness of anti-CGRP monoclonal antibodies and onabotulinumtoxinA in menstrually-related migraine: The unmet need of perimenstrual headache days. Cephalalgia. 45(4). 2235377575–2235377575. 1 indexed citations
2.
Iannone, Luigi Francesco, Antonio Russo, Anne Hege Aamodt, et al.. (2025). Combination preventive therapy with onabotulinumtoxinA and atogepant for chronic migraine: A 24-week, prospective, real-world evaluation (SYNERGY study). Cephalalgia. 45(12). 2235443067–2235443067.
3.
Muñoz‐Vendrell, Albert, A. López-Bravo, Almudena Layos-Romero, et al.. (2025). Effectiveness and safety of anti-CGRP monoclonal antibodies for migraine in patients over 65 years: a systematic review. Pain Management. 15(3). 161–171. 2 indexed citations
4.
Russo, Antonio, Marcello Silvestro, Anne Hege Aamodt, et al.. (2025). Effectiveness and tolerability of atogepant as preventive treatment in resistant individuals with chronic migraine: Six-month real-world evidence. Cephalalgia. 45(8). 2235415664–2235415664. 1 indexed citations
5.
Caronna, Edoardo, et al.. (2025). The interplay between migraine, endometriosis and polycystic ovarian syndrome: A systematic review. Cephalalgia. 45(12). 2235431832–2235431832.
6.
Alpuente, Alicia, Marta Torres‐Ferrús, Edoardo Caronna, & Patricia Pozo‐Rosich. (2024). The state of art on the use of patient reported outcomes in migraine. Current Opinion in Neurology. 37(3). 271–282. 2 indexed citations
7.
Caronna, Edoardo, et al.. (2024). Early and annual projected savings from anti-CGRP monoclonal antibodies in migraine prevention: a cost-benefit analysis in the working-age population. The Journal of Headache and Pain. 25(1). 21–21. 8 indexed citations
8.
Mitsikostas, Dimos D., Edoardo Caronna, Marina de Tommaso, et al.. (2024). Headaches and facial pain attributed to SARS‐CoV‐2 infection and vaccination: a systematic review. European Journal of Neurology. 31(6). e16251–e16251. 7 indexed citations
9.
Caronna, Edoardo, Thomas C. van den Hoek, Hayrünnisa Bolay, et al.. (2023). Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review. Cephalalgia. 43(1). 2205176393–2205176393. 17 indexed citations
10.
Labastida‐Ramírez, Alejandro, Edoardo Caronna, Cédric Gollion, et al.. (2023). Mode and site of action of therapies targeting CGRP signaling. The Journal of Headache and Pain. 24(1). 125–125. 33 indexed citations
11.
Alberich, Manel, Edoardo Caronna, Victor J Gallardo, et al.. (2023). Estimation of the density of veins from susceptibility-weighted imaging by using Mamdani fuzzy-type rule-based system. Investigating the neurovascular coupling in migraine. NeuroImage Clinical. 39. 103489–103489. 2 indexed citations
12.
García‐Azorín, David, Almudena Layos-Romero, J. Porta‐Etessam, et al.. (2022). Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients. Cephalalgia. 42(8). 804–809. 56 indexed citations
13.
Alpuente, Alicia, et al.. (2021). Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacks. Cephalalgia. 42(3). 186–196. 49 indexed citations
14.
Alpuente, Alicia, Victor J Gallardo, Edoardo Caronna, Marta Torres‐Ferrús, & Patricia Pozo‐Rosich. (2021). In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention. A real-world evidence study. The Journal of Headache and Pain. 22(1). 151–151. 24 indexed citations
15.
Caronna, Edoardo, Alicia González‐Martínez, Almudena Layos-Romero, et al.. (2021). Persistent headache after COVID-19: Pathophysioloy, clinic and treatment. SHILAP Revista de lepidopterología. 1. S31–S36. 13 indexed citations
16.
Caronna, Edoardo & Patricia Pozo‐Rosich. (2021). Headache as a Symptom of COVID-19: Narrative Review of 1-Year Research. Current Pain and Headache Reports. 25(11). 73–73. 29 indexed citations
17.
Caronna, Edoardo, Victor J Gallardo, Alicia Alpuente, Marta Torres‐Ferrús, & Patricia Pozo‐Rosich. (2021). Epidemiology, work and economic impact of migraine in a large hospital cohort: time to raise awareness and promote sustainability. Journal of Neurology. 269(3). 1456–1462. 10 indexed citations
18.
Caronna, Edoardo, Victor J Gallardo, Alicia Alpuente, Marta Torres‐Ferrús, & Patricia Pozo‐Rosich. (2021). Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months. The Journal of Headache and Pain. 22(1). 120–120. 62 indexed citations
19.
Benemei, Silvia, Alejandro Labastida‐Ramírez, Nicoletta Brunelli, et al.. (2020). Persistent post-traumatic headache: a migrainous loop or not? The preclinical evidence. The Journal of Headache and Pain. 21(1). 90–90. 39 indexed citations
20.
Caronna, Edoardo & Amaal J. Starling. (2020). Update on Calcitonin Gene-Related Peptide Antagonism in the Treatment of Migraine. Neurologic Clinics. 39(1). 1–19. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Victor J Gallardo Breakdown of academic impact, for papers by Alicia Alpuente Breakdown of academic impact, for papers by Marta Torres‐Ferrús Breakdown of academic impact, for papers by Ana Beatriz Gago‐Veiga Breakdown of academic impact, for papers by Guus Schoonman Breakdown of academic impact, for papers by Bianca Raffaelli Breakdown of academic impact, for papers by Axel Heinze Breakdown of academic impact, for papers by Alejandro Labastida‐Ramírez Breakdown of academic impact, for papers by Marcello Silvestro Breakdown of academic impact, for papers by Eloísa Rubio‐Beltrán
Rankless by CCL
2026